Please login to the form below

Not currently logged in
Email:
Password:

Daklinza

This page shows the latest Daklinza news and features for those working in and with pharma, biotech and healthcare.

NICE backs three hepatitis C meds, turns down Duchenne drug

NICE backs three hepatitis C meds, turns down Duchenne drug

NICE issued positive final draft guidance for Gilead's Harvoni (sofosbuvir/ledipasvir), BMS' Daklinza (daclatasvir) and AbbVie's Viekirax (ombitasvir/paritaprevir/ritonavir), with or without Exviera (dasabuvir), making the new drugs ... Some patients

Latest news

More from news
Approximately 6 fully matching, plus 13 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
integrated medhealth communication

imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...

Latest intelligence

Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...
Digital technologies: Pharma’s answer to achieving net zero emissions?
...